Dr. Geraldine Walsh
In late April 2022, Canadian Blood Services’ research-informed request to remove eligibility criteria specific to men who have sex with men and instead use sexual behaviour-based screening for all donors was approved by Health Canada. Read on to learn about two published studies from Canadian Blood Services that contributed to the body of evidence supporting this change.
We teamed up with Science Borealis and the Centre for Blood Research to deliver the 2021-2022 Canadian Blood Services Lay Science Writing Competition. In a recently published blog post, Science Borealis interviewed the winner of that competition, Alexandra Witt, to learn about her creative process and how she crafted a winning piece of writing.
In this week’s post, three Master’s students describe how their research interviewing young adults about blood donation policies helped them understand the real value of qualitative research. Their insights highlight the value of this type of research to inform Canadian Blood Services as the organization looks to evolve donor screening approaches and engage more young people - the blood donors of the future.
Consider submitting a nomination for this prestigious award that recognizes individuals whose landmark contributions are recognized as both extraordinary and world class in the field of transfusion or transplantation medicine, stem cell or cord blood research in Canada and/or abroad. You have until May 16, 2022 to get your nominations in!
Read the entry that was awarded first place in this year’s “Science behind the scenes” Lay Science Writing Competition! Congratulations to the winner, graduate student Alexandra Witt. She identified high school students as her target audience and wrote an engaging piece that sheds light on the questions scientists ask when developing a new drug.
Dr. Cyrus Eduljee, associate director of portfolio management at Canadian Blood Services, explains how his group’s work supports the organization in bringing new products to the shelves and the importance of ensuring the organization is well prepared to withstand future shocks.
In January 2022, Canadian Blood Services introduced pathogen-reduced platelets, a product that is manufactured using pathogen-inactivation technology, at its Ottawa production site. By effectively damaging the nucleic acids of a number of pathogens, pathogen inactivation further reduces the risk of transfusion-transmitted infections—an especially important safeguard against new or emerging pathogens, or pathogens for which tests are not available.
The Canadian Blood Services Lay Science Writing Competition supports our trainee network to develop communication skills by challenging them to showcase their research using plain language.
A study conducted last year by Canadian Blood Services’ social scientist, Dr. Kelly Holloway, shows challenges and opportunities for on-campus student advocates as they engage with their peers to encourage blood and plasma donation, all while navigating the COVID-19 pandemic.
Development work by Canadian Blood Services’ product and process development group lays the groundwork for greater operational flexibility for blood operators looking to introduce whole blood for transfusion.